Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
Anne RoussinThomas SoeiroCharlotte FouqueEmilie JouanjusElisabeth FraugerNathalie FouilhéMichel MallaretJoëlle MicallefMaryse Lapeyre Mestrenull nullPublished in: British journal of clinical pharmacology (2022)
The triangulation of the data obtained through addictovigilance monitoring evidenced a recent increase in high-risk tramadol use. These findings have a practical impact on the limitation of the maximal duration of tramadol prescriptions.